You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

SOLUPREP Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Soluprep patents expire, and when can generic versions of Soluprep launch?

Soluprep is a drug marketed by 3m Health Care and is included in one NDA.

The generic ingredient in SOLUPREP is chlorhexidine gluconate; isopropyl alcohol. There are fifty-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate; isopropyl alcohol profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SOLUPREP?
  • What are the global sales for SOLUPREP?
  • What is Average Wholesale Price for SOLUPREP?
Summary for SOLUPREP
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:SOLUPREP at DailyMed
Drug patent expirations by year for SOLUPREP
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for SOLUPREP
Generic Entry Date for SOLUPREP*:
Constraining patent/regulatory exclusivity:
REVISIONS TO THE LABELING TO DESCRIBE MODIFIED FORMULATION BASED ON RESULTS OF STUDIES EM-05-014624 AND EM-05-014815
NDA:
Dosage:
SOLUTION;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for SOLUPREP

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Centre for Interdisciplinary Research in Rehabilitation of Greater MontrealPhase 4
Claire BourgeoisPhase 4
Fédération des médecins résidents du QuébecPhase 4

See all SOLUPREP clinical trials

US Patents and Regulatory Information for SOLUPREP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m Health Care SOLUPREP S chlorhexidine gluconate; isopropyl alcohol SOLUTION;TOPICAL 208288-001 Aug 8, 2018 OTC Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

SOLUPREP Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for 3M SoluPrep S Sterile Antiseptic Solution

Introduction to 3M SoluPrep S

3M SoluPrep S sterile antiseptic solution is a significant product in the antiseptics and disinfectants market, particularly in the context of surgical skin preparation. This solution, containing chlorhexidine gluconate (2% w/v) and isopropyl alcohol (70% v/v), is designed to provide fast-acting, broad-spectrum antimicrobial activity.

Market Growth Drivers

The market for antiseptics and disinfectants, including products like 3M SoluPrep S, is driven by several key factors:

  • Increasing Awareness of Infectious Diseases: The global emphasis on infection control, especially in the wake of pandemics, has intensified the demand for effective antiseptics and disinfectants[2].
  • Expanding Healthcare Infrastructure: The growing healthcare infrastructure in developing countries and the rising number of hospitals and healthcare facilities are significant drivers. For instance, the hospital segment acquired a huge market revenue share of 69.8% in 2023 due to the rising incidence of hospital-acquired infections[1].
  • Technological Advancements: Innovations in formulations and delivery methods, such as the development of novel antiseptic solutions, contribute to the market’s growth. The launch of 3M SoluPrep S, with its enhanced antimicrobial activity, is a prime example of such innovation[2].

Financial Trajectory of the Antiseptics and Disinfectants Market

The global antiseptics and disinfectants market, which includes products like 3M SoluPrep S, is projected to experience substantial growth:

  • Current Market Size: The global antiseptics and disinfectants market was valued at USD 31.42 Billion in 2023[2].
  • Forecasted Growth: The market is expected to grow at a CAGR of 10.52% from 2024 to 2030, reaching nearly USD 63.28 Billion by 2030[2].
  • Long-Term Projections: Another forecast suggests that the market could be worth around USD 104.0 Billion by 2033, growing at a CAGR of 10.3% from 2024 to 2033[1].

Regional Insights

The demand for antiseptics and disinfectants varies by region, with some areas showing more significant growth potential:

  • North America: This region currently dominates the market, driven by a well-established healthcare infrastructure and high healthcare spending. North America had a revenue share of about 35% in 2023 and is expected to grow at a CAGR of 10.8% during the forecast period[2].
  • Asia Pacific: This region is expected to emerge as the most lucrative market due to rising healthcare standards and growing medical tourism in countries like India and China. It is anticipated to grow at a CAGR of 10.5% between 2024 and 2030[2].

Competitive Landscape

The market for antiseptics and disinfectants is highly competitive, with several key players:

  • Major Players: Companies like 3M Company, Procter & Gamble Co., Ecolab, Inc., The Clorox Company, and Johnson & Johnson are prominent in the market. These companies are engaged in product development and strategic alliances to cater to the growing global demand[1][2].
  • Recent Developments: For example, 3M Health Care launched its new FDA-approved 3M SoluPrep S sterile antiseptic solution in April 2023, which demonstrated fast-acting and broad-spectrum antimicrobial activity[2].

Performance and Benefits of 3M SoluPrep S

3M SoluPrep S sterile antiseptic solution offers several benefits that contribute to its market success:

  • Fast-Acting Antimicrobial Activity: This solution provides quick and effective skin preparation before surgery, reducing the risk of surgical site infections[5].
  • Persistence: It has been shown to maintain antimicrobial activity for at least 96 hours post-preparation, which is a significant advantage in infection control[2].
  • User-Friendly: The solution is designed to be easy to use, making it a preferred choice in both hospital and homecare settings[5].

Challenges and Restraints

Despite the growth potential, the market faces some challenges:

  • Regulatory Hurdles: Stringent government regulations can delay the deployment of new products, affecting market growth[2].
  • Chemical Availability: Volatility in the availability of chemicals required to produce disinfectants and antiseptics can also impact market expansion[2].
  • Prolonged Use Risks: The increased risk from prolonged use of antiseptics and disinfectants is another factor that could restrain market growth[2].

Key Takeaways

  • The global antiseptics and disinfectants market is poised for significant growth driven by increasing awareness of infectious diseases and expanding healthcare infrastructure.
  • 3M SoluPrep S sterile antiseptic solution is a key product in this market, offering fast-acting and persistent antimicrobial activity.
  • The market is expected to reach nearly USD 63.28 Billion by 2030, with North America and Asia Pacific being key regions driving growth.
  • Major players are focusing on product development and strategic alliances to capture market share.

FAQs

  1. What are the primary drivers for the antiseptics and disinfectants market?

    • The primary drivers include increasing awareness of infectious diseases, expanding healthcare infrastructure, and technological advancements in antiseptic formulations[2].
  2. Which region is expected to lead the global antiseptics and disinfectants market during the forecast period?

    • North America currently dominates the market, but Asia Pacific is expected to emerge as a highly lucrative region due to rising healthcare standards and medical tourism[2].
  3. What are the benefits of using 3M SoluPrep S sterile antiseptic solution?

    • It offers fast-acting and broad-spectrum antimicrobial activity, persistence for at least 96 hours post-preparation, and is user-friendly[2][5].
  4. What are the major restraints for the antiseptics and disinfectants market?

    • The major restraints include regulatory hurdles, volatility in chemical availability, and risks associated with prolonged use of antiseptics and disinfectants[2].
  5. Who are the key players in the antiseptics and disinfectants market?

    • Key players include 3M Company, Procter & Gamble Co., Ecolab, Inc., The Clorox Company, and Johnson & Johnson, among others[1][2].

Cited Sources

  1. Market.us: Antiseptic And Disinfectants Market Growth | CAGR of 10.3%
  2. Maximize Market Research: Antiseptics and Disinfectants Market: Global Industry Analysis
  3. Solventum: 3M SoluPrep S sterile antiseptic solution
  4. Coherent Market Insights: Antiseptic Market - Share, Size and Industry Analysis

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.